BeOne Medicines Ag
(NASDAQ) ONC
BeOne Medicines Ag Financials at a Glance
Market Cap
$31.66BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$5.74B
Net Income (TTM)
$513.02M
EPS (TTM)
$4.48
P/E Ratio
69.06
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$308.52
Volume
14,740
Open
$307.88
Price
$308.52
Volume
14,740
Open
$307.88
Previous Close
$308.52
Daily Range
$303.56 - $308.92
52-Week Range
$241.45 - $385.22
Estimated Earnings Date
Aug 5, 2026
Dividend
$0.00
Beta (Volatility)
0.98 (Low)
Price
$308.52
Volume
14,740
Open
$307.88
Previous Close
$308.52
Daily Range
$303.56 - $308.92
52-Week Range
$241.45 - $385.22
Estimated Earnings Date
Aug 5, 2026
ONC News
Why Shares of BeiGene Popped Today
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BeOne Medicines Ag
Industry
Biotechnology
Sector
Health CareEmployees
12,000
CEO
John V. Oyler, MBA
Website
beonemedicines.comHeadquarters
Basel, PA 4051, US
ONC Financials
Key Financial Metrics (TTM)
Gross Margin
87.17%
Operating Margin
11.96%
Net Income Margin
8.93%
Return on Equity
12.10%
Return on Capital
7.03%
Return on Assets
6.00%
Earnings Yield
1.45%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$31.66BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
102.30M
Volume
14.74K
Avg. Volume
257.15K
Financials (TTM)
Gross Profit
$5.07B
Operating Income
$685.94M
EBITDA
$901.83M
Operating Cash Flow
$1.29B
Capital Expenditure
-$438.89M
Free Cash Flow
$846.54M
Cash & ST Invst.
$4.79B
Total Debt
$1.15B
BeOne Medicines Ag Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.51B
+35.5%
Gross Profit
$1.35B
+41.4%
Gross Margin
88.95%
N/A
Market Cap
$31.66BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.64M
N/A
Employees
12,000
N/A
Net Income
$227.36M
+17802.1%
EBITDA
$333.25M
+449.0%
Quarterly Fundamentals
Total Cash
$4.79B
+90.4%
Total Debt
$1.15B
+15.3%
Accounts Receivable
$948.36M
+27.1%
Inventory
$681.59M
+37.8%
Long Term Debt
$1.01B
+370.7%
Short Term Debt
$136.72M
-82.5%
Return on Assets
6.00%
N/A
Return on Invested Capital
10.20%
N/A
Free Cash Flow
$161.03M
+322.6%
Operating Cash Flow
$201.94M
+358.1%